US Gastrointestinal Device Market to Surpass $9.3B, Driven by Rising GI Conditions and Advanced Screening Adoption

June 17, 2024 09:45 AM EDT | By EIN Presswire
 US Gastrointestinal Device Market to Surpass $9.3B, Driven by Rising GI Conditions and Advanced Screening Adoption
Image source: EIN Presswire

VANCOUVER, BC, CANADA, June 17, 2024 /EINPresswire.com/ -- iData Research, a leading international market research firm, proudly announces the release of its comprehensive market report on the United States gastrointestinal (GI) endoscopic devices sector. This report provides in-depth market data, forecasts, and analysis of key competitors, offering valuable insights into the current trends and future outlook of the GI endoscopic devices market.

The demand side of the GI endoscopic devices market is experiencing significant consolidation, with hospitals acquiring outpatient facilities and the expanding influence of group purchasing organizations (GPOs). Alongside these developments, reimbursement cuts across the GI space are placing downward pressure on average selling prices, which is expected to limit market growth throughout the forecast period.

Despite these challenges, several factors are anticipated to drive market growth. The increasing prevalence of GI-related conditions, the surge in colorectal cancer screening programs, and the adoption of new technologies are key contributors. Notably, innovations such as FIT-DNA tests (like Exact Sciences' Cologuard) and single-use endoscopes are expected to experience significant growth over the forecast period.

Advances in technology and the rising adoption of single-use devices are particularly noteworthy. Emerging products, such as single-use colonoscopes and gastroscopes from leading companies like Ambu and Boston Scientific, address critical needs for infection prevention and operational efficiency in healthcare settings. These innovations are anticipated to gain substantial market share and drive overall market growth.

US GI Endoscopic Devices Market Insights

Technology and Innovation

The US GI endoscopic devices market is poised for significant advancements with the introduction of single-use devices and innovative screening technologies. The adoption of FIT-DNA tests and single-use endoscopes is expected to grow, driven by their effectiveness in improving diagnostic accuracy and reducing the risk of cross-contamination.

Market Dynamics

The consolidation trend among healthcare facilities and the expanding reach of GPOs are reshaping the demand landscape. While these developments put pressure on average selling prices, the growing need for advanced diagnostic and therapeutic tools for GI conditions presents opportunities for market growth.

Future Outlook

Despite the pressures from reimbursement cuts and market consolidation, the US GI endoscopic devices market is set for a net positive growth trajectory. The increasing prevalence of GI-related conditions, the adoption of advanced screening programs, and technological innovations are expected to drive market expansion over the forecast period.

The report offers extensive data on market sizes, unit sales, detailed competitive analysis, and forecasts that include the implications of current market dynamics. This valuable information serves as a strategic tool for existing and potential market participants in understanding the competitive landscape and identifying market trends.

For more details or to purchase the report, please visit the link below:

https://idataresearch.com/product/gastrointestinal-endoscopic-devices-market-united-states/

About iData

iData Research stands out as the premier market research and intelligence provider, offering unparalleled insights and comprehensive data analysis across a multitude of industries. With a strong reputation and a proven track record, iData Research has solidified its position as the best choice for businesses seeking to make informed decisions in today's dynamic market landscape.

Why Choose iData?

Extensive Industry Coverage: Spanning healthcare, medical devices, dental, pharmaceuticals, biotechnology, and more, iData ensures accurate, up-to-date information relevant to diverse business goals.

High-Quality Data: Commitment to rigorous methodologies and reliable sources ensures clients receive accurate, actionable information.

In-Depth Analysis: Beyond data presentation, iData offers holistic analysis of market trends, dynamics, and competitive landscapes.

Customized Solutions: Tailored offerings cater to specific client needs, from startups to multinational corporations.

Timely Updates: Real-time information equips clients to make agile decisions and adapt swiftly to market changes.

Global Perspective: Insights into various geographic markets enable informed decisions regardless of business location.

Trusted by Industry Leaders: iData's client list includes major players relying on their insights for strategic planning.

Emma Matrick
iData Research
+1 604-266-6933
email us here
Visit us on social media:
Facebook
X
LinkedIn


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media Incorporated (“Kalkine Media, we or us”), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used in the Content are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.